LUXIR Trademark

Trademark Overview

On Wednesday, September 6, 2023, a trademark application was filed for LUXIR with the United States Patent and Trademark Office. The USPTO has given the LUXIR trademark a serial number of 98166711. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 4, 2025. This trademark is owned by KIMERA LABS, Inc.. The LUXIR trademark is filed in the Pharmaceutical Products category with the following description:

Medicated topical serums for treatment of skin containing proteins, enzymes, growth factors, and exosomes derived from mesenchymal stem cells (MSCs)
luxir

General Information

Serial Number98166711
Word MarkLUXIR
Filing DateWednesday, September 6, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2025

Trademark Statements

Goods and ServicesMedicated topical serums for treatment of skin containing proteins, enzymes, growth factors, and exosomes derived from mesenchymal stem cells (MSCs)

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 28, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKIMERA LABS, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMiramar, FL 33025
Party NameKIMERA LABS, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiramar, FL 33025

Trademark Events

Event DateEvent Description
Saturday, September 9, 2023NEW APPLICATION ENTERED
Thursday, September 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 2, 2024NON-FINAL ACTION E-MAILED
Monday, August 26, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, August 26, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, October 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 8, 2024PETITION TO REVIVE-GRANTED
Tuesday, October 8, 2024NOTICE OF REVIVAL - E-MAILED
Tuesday, October 8, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, May 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 2, 2024ASSIGNED TO EXAMINER
Thursday, May 2, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 27, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, November 27, 2024FINAL REFUSAL E-MAILED
Wednesday, November 27, 2024FINAL REFUSAL WRITTEN
Friday, February 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 10, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 4, 2025PUBLISHED FOR OPPOSITION
Friday, February 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 7, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED

Related Keywords

luxir from derived exosomes mesenchymal stem mscs cells factors growth treatment